Cancer News and Research

Latest Cancer News and Research

GRNCM1 do not cause cardiac arrhythmias after transplantation: Preclinical study

Geron Corporation today reported positive preclinical study data showing that GRNCM1, Geron's cardiomyocyte product derived from human embryonic stem cells, does not cause cardiac arrhythmias after transplantation into a model of chronic heart damage designed to test this potential safety concern.

14 May 2010

Increase in use of imaging scans underscores need for evidence-based protocols in cancer care

New research showing a more than 30 percent annual increase in the use of high-tech imaging scans in older cancer patients underscores the need for evidence-based protocols in cancer care, said MedSolutions, a leading provider of medical management services.

14 May 2010

Smoking, obesity and alcohol use associated with poorer survival of non-Hodgkin's lymphoma patients

A new study led by researchers from Mayo Clinic in collaboration with six other U.S. institutions has found that patients with non-Hodgkin's lymphoma who smoked, consumed alcohol or were obese before their cancer diagnosis had poorer overall survival, compared to patients who did not have these risk factors.

14 May 2010

DMC recommends Celsion to continue enrollment in ThermoDox clinical study for primary liver cancer

Celsion Corporation announced today that after reviewing data from 294 patients including data from 12 Japanese patients enrolled in the pivotal Phase III ThermoDox® clinical study (HEAT Study) for primary liver cancer, the Data Monitoring Committee (DMC) has recommended that Celsion continue to enroll patients in the trial.

14 May 2010

Jennerex to present key data on JX-594 Phase 1 dose escalation clinical study at ASGCT Annual Meeting

Jennerex, Inc., a clinical-stage cancer biotherapeutics company, today announced that key data from its JX-594 intravenous administration Phase 1 dose escalation clinical study will be presented at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting taking place May 19-22, 2010, in Washington DC.

14 May 2010

Phase IIb trail results of epratuzumab in lupus patients to be presented at EULAR 2010

Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that clinical trial results on epratuzumab, the anti-CD22 humanized monoclonal antibody licensed to UCB SA, Brussels, for autoimmune disease indications, from the Phase IIb study in patients with lupus, will be presented in four posters sessions and one published abstract.

14 May 2010

CIGNA adds CTCA to national network

Recognizing the importance of access, quality and choice for its many customers who have been touched by cancer, CIGNA has entered into a new agreement that opens the doors to comprehensive, integrative care at Cancer Treatment Centers of America (CTCA).

14 May 2010

Study results of Cameron Health's S-ICD- System published online in NEJM

Cameron Health, Inc. today announced the publication of study results online in the New England Journal of Medicine highlighting the development and potential benefits of the company's S-ICD- System, the first minimally invasive, subcutaneous implantable cardioverter defibrillator, for the treatment of sudden cardiac arrest.

14 May 2010

Response Genetics first-quarter total revenue up 140%

Response Genetics Inc., a company focused on the development and sale of molecular diagnostic tests for cancer, today announced its consolidated financial results for the three months ended March 31, 2010.

14 May 2010

Minnesota lawmakers debate budget, Medicaid expansion

More budget talks were expected Thursday as Minnesota's legislative session hurtled toward a midnight Sunday deadline with no deal on a $3 billion deficit. The Democratic-controlled Legislature defied another veto threat from Republican Gov. Tim Pawlenty late Wednesday and sent him a health and welfare package he opposes.

14 May 2010

Guided Therapeutics first-quarter service revenue increases to $821,000

Guided Therapeutics, Inc. today announced its operating results for the first quarter of 2010.

14 May 2010

GOP launches attacks on CMS nominee Berwick

Republicans have begun attacking Donald Berwick, a doctor and Harvard professor nominated to head the Obama administration's Medicare and Medicaid agency, The Boston Globe reports. If confirmed, Berwick would run the Centers for Medicare and Medicaid Services, an agency with 4,500 employees and an annual budget of $780 billion.

14 May 2010

Merit Medical Systems to acquire BioSphere Medical

Merit Medical Systems, Inc. today announced that it has signed a definitive merger agreement to acquire BioSphere Medical, Inc. in an all cash transaction valued at approximately $96 million, inclusive of all common equity and Series A Preferred preferences.

14 May 2010

Groups plead for more health funding as Chairman warns about cuts to proposed HHS budget

House Appropriations Committee Chairman David Obey, D-Wis., said Wednesday that groups pressing for $14 billion more in funding for education, health and labor programs will likely be disappointed because the budget proposed by President Barack Obama already faces cuts of about $3.5 billion in those areas.

14 May 2010

Cyclacel Pharmaceuticals reports net loss of $5.1M for first-quarter 2010

Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today reported its financial results and business highlights for the first quarter ended March 31, 2010.

14 May 2010

Rexahn Pharmaceuticals announces Phase IIb clinical trial of Zoraxel for ED

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it will initiate a Phase IIb clinical trial for ZoraxelTM in the treatment of erectile dysfunction (ED).

13 May 2010

TechniScan awarded U.S. Patent for 3-D, Warm Bath Ultrasound system

A newly awarded U.S. Patent will protect TechniScan, Inc's., novel way to image, biopsy and treat breast cancer.

13 May 2010

Genta first-quarter net loss increases to $166.6 million

Genta Incorporated today announced financial results for the quarter ended March 31, 2010.

13 May 2010

Arrowhead decreases second-quarter consolidated operating expenses by 58%

Arrowhead Research Corporation today announced financial results for its fiscal 2010 second quarter ended March 31, 2010.

13 May 2010

Researchers provide better understanding of anti-cell death proteins and potential antagonist to defeat them

Cancer uses devious means to evade treatment and survive. One prime example is the way tumors express anti-cell death (anti-apoptotic) proteins to resist chemotherapy and radiation. However, the Pellecchia laboratory at Sanford-Burnham Medical Research Institute has made two recent discoveries that may help curb these anti-apoptotic proteins and make current treatments more effective.

13 May 2010

Cancer News and Research

Latest Cancer News and Research

GRNCM1 do not cause cardiac arrhythmias after transplantation: Preclinical study

Increase in use of imaging scans underscores need for evidence-based protocols in cancer care

Smoking, obesity and alcohol use associated with poorer survival of non-Hodgkin's lymphoma patients

DMC recommends Celsion to continue enrollment in ThermoDox clinical study for primary liver cancer

Jennerex to present key data on JX-594 Phase 1 dose escalation clinical study at ASGCT Annual Meeting

Phase IIb trail results of epratuzumab in lupus patients to be presented at EULAR 2010

CIGNA adds CTCA to national network

Study results of Cameron Health's S-ICD- System published online in NEJM

Response Genetics first-quarter total revenue up 140%

Minnesota lawmakers debate budget, Medicaid expansion

Guided Therapeutics first-quarter service revenue increases to $821,000

GOP launches attacks on CMS nominee Berwick

Merit Medical Systems to acquire BioSphere Medical

Groups plead for more health funding as Chairman warns about cuts to proposed HHS budget

Cyclacel Pharmaceuticals reports net loss of $5.1M for first-quarter 2010

Rexahn Pharmaceuticals announces Phase IIb clinical trial of Zoraxel for ED

TechniScan awarded U.S. Patent for 3-D, Warm Bath Ultrasound system

Genta first-quarter net loss increases to $166.6 million

Arrowhead decreases second-quarter consolidated operating expenses by 58%

Researchers provide better understanding of anti-cell death proteins and potential antagonist to defeat them

Cancer Research - Second Edition eBook

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Newsletters you may be interested in